Overview

To Evaluate the Drug-drug Interaction Between Telmisartan and Atorvastatin in Healthy Male Volunteers

Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The study design was composed of 2 parts, 2-way crossover and multiple-dose. There are having 2 groups in each part that have divided period 1 and period 2, and wash-out period is 16 days between periods. Each group is taking Telmisartan (80mg) and/or Atorvastatin (80mg) once a day for 6 days.
Phase:
Phase 1
Details
Lead Sponsor:
Samil Pharmaceutical Co., Ltd.
Treatments:
Atorvastatin
Atorvastatin Calcium
Telmisartan